Skip to main content

Day: June 29, 2020

XP Inc. Announces Proposed Public Secondary Offering of Class A Common Shares

SÃO PAULO, Brazil, June 29, 2020 (GLOBE NEWSWIRE) — XP Inc., or XP (Nasdaq: XP), announced today the commencement of an underwritten public offering of 19,535,420 Class A common shares to be offered by General Atlantic (XP) Bermuda, L.P and XP Controle Participações S.A. pursuant to a registration statement on Form F-1 filed with the U.S. Securities and Exchange Commission (“SEC”). In connection with the offering, the selling shareholders intend to grant the underwriters the option to purchase up to 2,930,313 additional Class A common shares.XP will not receive any proceeds from the sale of Class A common shares by the selling shareholders.XP Investimentos, Morgan Stanley, Goldman Sachs & Co. LLC and J.P. Morgan are acting as Global Coordinators in this offering, and XP Investimentos, Morgan Stanley, Goldman Sachs & Co....

Continue reading

Team, Inc. to Present at the Sidoti & Company Inaugural Microcap Virtual Investor Conference

SUGAR LAND, Texas, June 29, 2020 (GLOBE NEWSWIRE) — Team, Inc. (“TEAM” or the “Company”) (NYSE: TISI), a global leading provider of integrated, digitally-enabled asset performance assurance and optimization solutions, announced today that its senior management will present at the Sidoti & Company Inaugural Microcap Virtual Investor Conference on June 30, 2020.Amerino Gatti, Chairman & Chief Executive Officer, and Susan Ball, EVP & Chief Financial Officer, will provide an overview of TEAM during a presentation on Tuesday, June 30 at approximately 11:30 a.m. Eastern Time (10:30 a.m. Central Time). Mr. Gatti and Ms. Ball will also be participating in virtual one-on-one meetings for registered Sidoti clients throughout the conference. A copy of the presentation will be available that day in the Investor Relations section...

Continue reading

Acura Pharmaceuticals Announces First Quarter 2020 Financial Results

PALATINE, Ill., June 29, 2020 (GLOBE NEWSWIRE) — Acura Pharmaceuticals, Inc. (OTCQB: ACUR), a specialty pharmaceutical company engaged in the research, development and commercialization of technologies and product candidates intended to mitigate the risk of outcomes associated with product misuse, announced today financial results for the three months ended March 31, 2020.The Company reported revenues of $1.1 million and an operating loss of $483 thousand for the first quarter 2020 compared to revenues of only $67 thousand and an operating loss of $683 thousand for the same period in 2019.  Included in expenses for the first quarter 2020 was a one-time charge of $668 thousand to recognize an impairment in our Aversion intangible asset.The Company reported a net loss of $595 thousand or $0.02 per diluted share for the first quarter...

Continue reading

MONMOUTH REAL ESTATE REPORTS STRONG OCCUPANCY AND RENT COLLECTION RESULTS DURING THE COVID-19 PANDEMIC

HOLMDEL, NJ, June 29, 2020 (GLOBE NEWSWIRE) — Monmouth Real Estate Investment Corporation (NYSE:MNR) reported today that its occupancy rate from March 1, 2020 through June 30, 2020 averaged 99.4%. Rent collections throughout this period were as follows:March 100%, April 99%, May 98%, June 99%.Michael P. Landy, President and CEO, commented, “We are very pleased to report these excellent results. Our high-quality portfolio of modern, net-leased industrial properties secured by long-term leases to investment grade tenants continues to provide our shareholders with reliable and predictable income streams. These resilient results during such volatile times highlights the mission-critical nature of our portfolio and underscores the essential need for our tenants’ operations.Monmouth Real Estate Investment Corporation, founded in 1968,...

Continue reading

Allied Hotel Properties Inc. Provides Interim Filings Update

VANCOUVER, British Columbia, June 29, 2020 (GLOBE NEWSWIRE) — Allied Hotel Properties Inc. (“Allied” or the “Company”) (TSX-V: AHP) is providing an update on the status of the filing of its interim financial report and accompanying management’s discussion and analysis for the three-month period ended March 31, 2020 (collectively, the “Interim Filings”) which were required to be filed by May 30, 2020 under National Instrument 51-102 Continuous Disclosure Obligations.As previously announced on May 19, 2020, the Company is relying on the 45-day filing extensions being offered by various securities regulators in Canada, in response to the COVID-19 pandemic, for certain periodic filings that are required to be made on or before June 1, 2020. Specifically, Allied is relying on the exemptions with respect to the Interim Filings in accordance...

Continue reading

Hub Group, Inc. Schedules Second Quarter 2020 Earnings Conference Call

OAK BROOK, Ill., June 29, 2020 (GLOBE NEWSWIRE) — Hub Group, Inc. (Nasdaq: HUBG) will hold a conference call at 5:00 p.m. Eastern Time on Thursday, July 30, 2020 to discuss its second quarter 2020 results. The results will be announced via press release after the market closes on the day of the call.Hosting the conference call will be Dave Yeager, Chairman and Chief Executive Officer. Also participating on the call will be Phil Yeager, President and Chief Operating Officer, and Geoff DeMartino, Executive Vice President, Chief Financial Officer and Treasurer.This call is being webcast and can be accessed through the Investors link on Hub Group’s web site at www.hubgroup.com.  The webcast is listen-only.  Those interested in participating in the question and answer session should follow the telephone dial-in instructions below.To...

Continue reading

POET Technologies Extends Exercise Period for Warrants from 2018 Public Offering

TORONTO, June 29, 2020 (GLOBE NEWSWIRE) — POET Technologies, Inc. (OTCQX: POETF; TSX Venture: PTK) the designer and developer of the POET Optical Interposer™ and Photonic Integrated Circuits (PICs) for the data center and telecommunication markets, today announced the Company has extended the expiry of warrants granted to investors in connection with its March 2018 public offering managed by Cormark Securities Inc. based in Toronto, Ontario, Canada.The Company has extended the exercise period to September 30, 2020 for a total of 12,545,350 common share purchase warrants, all of which are exercisable at C$0.75 per share (collectively, the “Warrants”).  These existing Warrants were issued pursuant to a public offering completed by Cormark on March 21, 2018 with a two-year period in which to exercise.  The expiry of the Warrants was...

Continue reading

Arbor Realty Trust, Inc. Closes Additional $30 Million of its Senior Unsecured Notes due 2023, for a Total Issuance of $71 Million

UNIONDALE, N.Y., June 29, 2020 (GLOBE NEWSWIRE) — Arbor Realty Trust, Inc. (the “Company”) (NYSE:ABR) announced today that it has closed the private placement of $30 million aggregate principal amount of 8.00% senior unsecured notes due April 30, 2023 (the “Reopened Notes”). The Reopened Notes are a further issuance of and form a single series with the $40 million aggregate principal amount of 8.00% senior unsecured notes due April 30, 2023 initially issued by the Company on April 24, 2020  (the “Initial Notes” and, together with the Reopened Notes, the “Notes”). Following this offering, the aggregate outstanding principal amount of the Notes is $70,750,000.The Company intends to use the net proceeds from the offering to repay secured indebtedness, make investments relating to its business and for general corporate purposes. Piper...

Continue reading

Vaxil Announces Private Placement Extension

Not for distribution by US newswire or in United StatesNESS-ZIONA, Israel, June 29, 2020 (GLOBE NEWSWIRE) — VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative immunotherapy biotech company specializing in cancer and infectious diseases, would like to provide an update on its previously announced brokered private placement of up to 58,823,530 units of the Company with minimum gross proceeds of $2,000,000 (the “Offering“), with M Partners Inc. as Lead Agent. The Offering remains in progress and the closing date has been extended and is expected to occur on or about July 17, 2020. Further details of the Offering are included in the Company’s press release from May 26, 2020.Net proceeds from the Offering will be used by the Company for continued pre-clinical research supporting development of the...

Continue reading

CRISPR Therapeutics Announces Proposed Offering of Common Shares

ZUG, Switzerland and CAMBRIDGE, Mass., June 29, 2020 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq:CRSP), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, today announced that it is commencing an underwritten public offering of $325,000,000 of common shares. In addition, the underwriters will have a 30-day option to purchase up to an additional $48,750,000 of common shares at the public offering price less the underwriting discount.Goldman Sachs & Co. LLC, BofA Securities and Jefferies are acting as joint book-running managers for the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering.The common shares will be offered and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.